使用智能制药技术方法设计含有克洛法胺的脂质纳米颗粒
Helena Rouco1,2,3, Nicola Filippo Virzì4, Carolina Menéndez-Rodríguez5
1Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, Grupo I+D Farma (GI-1645), Facultad de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Pharmaceutics
|July 30, 2025
概括
这项研究使用纳米结构脂质载体 (NLC) 开发了改进的克洛法齐明 (CFZ) 抗菌配方. 智能制药技术增强了药物输送,显示出有希望的生物相容性和对黄金葡萄球菌的有效性.
科学领域:
- 制药技术 制药技术 制药技术
- 纳米医学是一种纳米医学.
- 抗菌药物药物交付 抗菌药物药物交付
背景情况:
- 克洛法齐明 (CFZ) 具有广泛的抗菌活性,但由于溶解性差和副作用而面临限制.
- 纳米结构脂质载体 (NLCs) 为提高药物的生物可用性和安全性提供了一个有希望的策略.
- 开发有效的纳米粒子配方存在重大挑战.
研究的目的:
- 使用智能制药技术开发优化Clofazimine装载的纳米结构脂质载体 (CFZ-NLCs).
- 为了利用人工智能 (AI) 和神经模糊逻辑 (NFL) 来制定设计和理解.
- 评估开发的CFZ-NLCs的生物相容性和抗菌疗效.
主要方法:
- 应用AI建立的设计空间用于CFZ-NLC配方开发.
- 使用神经模糊逻辑 (NFL) 和in silico对接来分析NLC组件相互作用.
- 配方生物相容性与小鼠纤维细胞和抗菌活性对*黄金葡萄球菌*的表征.
主要成果:
- 成功开发具有最佳特性的CFZ-NLC,包括小颗粒大小和高药载荷.
- NFL提供了对NLC组件相互作用和对配方性质的同质化效应的见解.
- 在接中证实了药物-脂质矩阵相互作用,配方显示出良好的生物相容性和抗菌活性.
结论:
- 智能制药战略,包括人工智能和NFL,促进了先进的抗微生物药物输送系统的高效设计.
- 开发的CFZ-NLC显示了改善抗微生物治疗的潜力.
- 这种方法可以更有效地开发基于纳米粒子的新型药物递送系统.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
350
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
350
Biopharmaceutical Factors Influencing Drug Product Design: Overview
541
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
541
Modified-Release Drug Delivery Systems: Site-Targeted
161
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
161
Site-Targeted Drug Delivery Systems: Polymeric Carriers
156
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
156


